References

Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care. 2015; 60:(3)455-68 https://doi.org/10.4187/respcare.03200

Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P Concordance is not synonymous with compliance or adherence. Br J Pharmacol. 2007; 64:(5)710-71 https://doi.org/10.1111/j.1365-2125.2007.02971_1.x

Bender BG. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?. Curr Opin Pulm Med. 2014; 20:(2)132-7 https://doi.org/10.1097/MCP.0000000000000027

The antibiotic course has had its day. BMJ. 2017; 358 https://doi.org/10.1136/bmj.j3418

Burge G, Ahitan B, Briggs E, Neighbour K, Aldrick H, Moore V, Walters G, Burge S Adherence to anti-fibrotic therapy in IPF; the nurses' challenge. European Respiratory Journal. 2017; 50 https://doi.org/10.1183/1393003.congress-2017.OA3235

Courtney M, Rowbotham S, Lim R, Deslandes R, Hodson K, MacLure K, Peters S, Steward D Antibiotics for acute respiratory tract infections: a mixed-methods study of patient experiences of non-medical prescriber. Respir Care. 2015; 60:(3)455-68 https://doi.org/10.1111/j.1365-2648.2012.05960.x

Duffy E, Ritchie S, Metcalf S, Van Bakel B, Thomas MG. Antibacterials dispensed in the community comprise 85%-95% of total human antibacterial consumption journal of clinical pharmacy and therapeutics.: Wiley Online Library; 2017 https://doi.org/10.1111/jcpt.12610

Elias C, Moja C, Mertz D, Loeb M, Forte g, Magrini N Guideline recommendations and antimicrobial resistance: the need for change. BMJ open. 2017; 7:1-8

Fernandes M, Leite A, Basto M, Nobre MA, Vieira N, Fernandes R, Nogueira P, Nicola PJ Non-adherence to antibiotic therapy in patients visiting community pharmacies. Int J Clin Pharm. 2014; 36:(1)86-91 https://doi.org/10.1007/s11096-013-9850-4

Horne R. Compliance, Adherence, and Concordance. Chest. 2006; 130:(1)65S-72S https://doi.org/10.1378/chest.130.1_suppl.65s

GOV.UK. Writing for GOV.UK - Content design: planning, writing and managing content - Guidance. 2016. http://www.gov.uk (accessed 4 December 2019)

Harris Interactive. Out-of-pocket costs may be a substantial barrier to prescription drug compliance (PDF). 2016. https://harris-ineractive.co.uk (accessed 10 December 2019)

Health.Gov. Health Literacy - Fact Sheet: Health Literacy Basics. 2000. https://health.gov/communication/literacy/quickguide/factsbasic.htm (accessed 4 December 2019)

Jungst C, Graber S, Simons S, Wedemeyer H Lammert F Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. QJM: An International Journal of Medicine. 2019; 11:(7)505-512

Mathes T, Jaschinski T, Pieper D. Adherence influencing factors – a systematic review of systematic reviews. Arch Public Health. 2014; 72 https://doi.org/10.1186/2049-3258-72–37

Matthes j, Albus C Improving Adherence With Medication A Selective Literature Review Based on the Example of Hypertension Treatment. Dtsch Artebl Int. 2014; 111:(4) https://doi.org/10.3238/arztebl.2014.0041

NICE. Overview | Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | Guidance. 2009. https://www.nice.org.uk/Guidance/CG76 (accessed 4 December 2019)

National Institute for Health and Clinical Excellence. 2015 NHS Digital 2016. Prescription Cost Analysis: prescriptions dispensed in the community, 2016. 2017. http://www.gov.uk/government/statistics/prescription-cost-analysis-england-2016 (accessed 4 December 2019)

NHS Digital. Prescription Cost Analysis: prescriptions dispensed in the community. 2016. http://www.gov.uk/government/statistics/prescription-cost-analysis-england-2016 (accessed 4 December 2019)

Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. Journal of the National Cancer Institute. 2002; 94:(9)652-61

Raimundo K, Kong A, Gray S, Benloucif S, Limb S. Adherence and Persistence to Antifibrotic Treatments for Idiopathic Pulmonary Fibrosis. Chest. 2017; 152:(4) https://doi.org/10.1016/j.chest.2017.08.468

Royal Pharmaceutical Society. Medicines Optimisation Medicines Optimisation: Helping patients to make the most of medicines. 2013. https://www.rpharms.com/Portals/0/RPS%20document%20library/Open%20access/Policy/helping-patients-make-the-most-of-their-medicines.pdf (accessed 4 December 2019)

Smith DRM, Dolk FCK, Pouwels KB, Christie M, Robotham JV, Smieszek T. Defining the appropriateness and inappropriateness of antibiotic prescribing in primary care. Journal of Antimicrobial Chemotherapy. 2018; 73:ii11-ii18 https://doi.org/10.1093/jac/dkx503

World Health Organization (WHO). Adherence to Long-term Therapies. 2003. https://www.who.int/chp/knowledge/publications/adherence_report/en/ (accessed 4 December)

World Health Organisation (WHO). The Mandate for Health Literacy. 2015. https://www.who.int (accessed 10 December 2019)

Medicines adherence in respiratory disease

02 January 2020
Volume 2 · Issue 1

Abstract

In respiratory diseases, there are good pharmacological and non pharmacological therapeutic interventions that can improve symptoms, health status and quality of life for many, and in some cases transform and even save lives. What is not in place is a robust method for ensuring that the therapies and interventions that are prescribed or advised can and will be taken as instructed, and we call this nonadherence. This article looks at medicines adherence, using examples from respiratory diseases and their treatments, discussing what what is meant by it, the reasons it remains problematic, and what could be done about it in respiratory prescribing

Adherence is the term currently used to describe a patient following prescribed or suggested treatment regimens; in other words – the degree to which a patient correctly follows medical advice (Bell et al, 2007). Adherence was previously, and sometimes concomitantly, known as compliance and concordance, however these terms are not synonymous (Bell et al, 2007). Concordance does not refer to a patient's medicine-taking behaviour, but instead the nature of the interaction between clinician and patient (Bell et al, 2007).

Adherence is regarded as a major problem in all pharmacological interventions, with approximately half of all patients with chronic diseases not adhering to their medical regimens, so is not specific to respiratory diseases (Jungst, 2019).

Commonly, adherence refers to medication or drug compliance, but it also applies to interventions, such as the use of medical devices, self-directed exercise programmes, self-care, self-management, and therapy sessions such as pulmonary rehabilitation. It is known that both the person receiving the advice or prescription and the healthcare provider affect adherence, and it is said that a positive physician-patient relationship is the single most important factor in improving adherence; this finding has been consistent over time (World Health Organization (WHO), 2003; Mathes et al, 2014). The cost of prescription medication may also play a major role in adherence to therapies, although in 2016, 89.4% of prescriptions dispensed in England were free of charge so it is not the whole answer (National Institute of Clinical Excellence (NICE), 2009; NHS Digital, 2016).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month